Securities code: 300347 securities abbreviation: Hangzhou Tigermed Consulting Co.Ltd(300347) announcement code (2022) No. 005
Hangzhou Tigermed Consulting Co.Ltd(300347)
Announcement on the resolutions of the 14th meeting of the 4th board of supervisors
The company and all members of the board of supervisors guarantee that the contents of the announcement are true, accurate and complete, and shall be jointly and severally liable for false records, misleading statements or major omissions in the announcement.
The 14th meeting of the 4th board of supervisors of Hangzhou Tigermed Consulting Co.Ltd(300347) (hereinafter referred to as “the company”) was held in the conference room on the 18th floor, building 8, No. 19, Jugong Road, Binjiang District, Hangzhou on February 11, 2022. This meeting was held in the form of combination of on-site and communication voting. The notice of the meeting was sent to all supervisors by telephone and e-mail on February 10, 2022. Three supervisors should be present at the meeting and three actually present. The meeting was presided over by Zhang Binghui, chairman of the board of supervisors. The convening and procedures of this meeting meet the requirements of relevant laws, regulations and the articles of association, and the meeting is legal and effective.
After deliberation by the supervisors present at the meeting, the following resolutions were adopted by voting:
1、 The proposal on repurchase of shares of the company was deliberated and passed one by one.
Upon review, the company repurchases shares to implement the equity incentive plan or employee stock ownership plan, which complies with the company law of the people’s Republic of China, the securities law of the people’s Republic of China, the share repurchase rules of listed companies and other relevant provisions; It will help mobilize the enthusiasm of the company’s employees, better promote the sustainable and healthy development of the company and enhance the investment value of the company. The decision-making and deliberation procedures of this share repurchase are legal and compliant, and there is no situation that damages the interests of the company and minority shareholders. The board of supervisors of the company agrees to repurchase the company’s shares to implement the equity incentive plan or employee stock ownership plan.
See Hangzhou Tigermed Consulting Co.Ltd(300347) announcement on share repurchase scheme of the company disclosed at the same time on the information disclosure website designated by the China Securities Regulatory Commission on the gem for details.
1. Purpose and purpose of share repurchase
Voting results: 3 in favor, 0 against and 0 abstention. 2. Voting results of share repurchase method: 3 in favor, 0 against and 0 abstention. 3. Voting results of share repurchase price or price range and pricing principle: 3 in favor, 0 against and 0 abstention. 4. Voting results of total capital and capital source of Share Repurchase: 3 in favor, 0 against and 0 abstention. 5 Voting results of the type, quantity and proportion of repurchased shares in the total share capital: 3 in favor, 0 against and 0 abstention. 6. Voting results of the time limit of repurchased shares: 3 in favor, 0 against and 0 abstention. 7. Voting results of the validity of the resolution: 3 in favor, 0 against and 0 abstention. 8. Voting results of specific authorization for handling the repurchased shares: 3 in favor and 0 against, It is hereby announced that there are 0 abstentions.
Hangzhou Tigermed Consulting Co.Ltd(300347) board of supervisors February 14, 2002
